US-guided FICB After Hip Fracture: the Effect of the Local Anesthetic Volume on the Quality of Preoperative Analgesia
NCT ID: NCT04692857
Last Updated: 2021-01-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
75 participants
INTERVENTIONAL
2020-01-02
2020-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
for group 30 ,a volume of 30 ml of 0,2 % ropivacaine had been injected for group 40 ,a volume of 40 ml of 0,2 % ropivacaine had been injected for group 50 ,a volume of 50 ml of 0,2 % ropivacaine had been injected
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Comparison of the Ultrasound Supra-inguinal Fascia Iliaca Block vs Femoral Nerve Block
NCT04692428
Quality of Recovery After Hip Fracture Surgery: US-guided PENG Block Versus FICB
NCT05968014
Ultrasound Percapsular Nerve Group Block VS Fascia Iliaca Block for Hip Fracture
NCT04285333
Blind Fascia Iliaca Compartment Block Compared to Ultrasound-guided Femoral Nerve Block in Patients With Hip Fractures
NCT05365555
Comparing Suprainguinal Fascia Iliaca Block With Erector Spinae Plane Block in Hip and Proximal Femur Surgery
NCT05642975
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
A linear ultrasound probe was placed in the sagittal plane to obtain an image of the superior iliac spine.the fascia iliaca and sartorious,iliopsoas,and oblique internal muscles were identified by sliding the probe medially. After identifiying the "bow-tie sign"formed by the muscle fascias , an 50 mm needle was introduced 1-2 cm inferior to the inguinal ligament.using an in-plane approch, the fascia iliaca was penetrated and hydrodissected , separating the fascia iliaca from the iliac muscle. in this created space a total volume of 30 ml, 40ml or 50ml of 0.2% ropivacaine was injected , respectively to group 30 ,group 40 and group 50 .
pain score at rest and with a straight leg raise of the affected limb to 15 degrees were assessed before and 30 minutes after block performance.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
BASIC_SCIENCE
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
group 30
participants received a supra inguinal fascia iliaca compartment block with 30 ml of 0.2% ropivacaine
supra inguinal fascia iliaca block
injection of 30,40 or 50 ml of 0.2 ropivacaine .
group 40
participants received a supra inguinal fascia iliaca compartment block with 40 ml of 0.2% ropivacaine
supra inguinal fascia iliaca block
injection of 30,40 or 50 ml of 0.2 ropivacaine .
group 50
participants received a supra inguinal fascia iliaca compartment block with 50 ml of 0.2% ropivacaine
supra inguinal fascia iliaca block
injection of 30,40 or 50 ml of 0.2 ropivacaine .
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
supra inguinal fascia iliaca block
injection of 30,40 or 50 ml of 0.2 ropivacaine .
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* younger than 65 years
* BMI greater than 35 kg/m²
* presence of contraindications for regional nerve block or spinal anesthesia
* impaired cognition or dementia
* multiple fractures
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Tunis El Manar
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Mechaal Benali
professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
mechaal benali, PROFESSOR
Role: STUDY_CHAIR
university manar Tunis tunisia
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Mechaal Benali
Nabeul, Mrezga, Tunisia
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
UTEM VOL FIBSI
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.